SubHero Banner
Text

Xepi (ozenoxacin) – New drug approval

December 11, 2017 – The FDA approved Ferrer Internacional’s Xepi (ozenoxacin), for the topical treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older.

Download PDF